Optofluidic Platform for Antibody Discovery (COVID-19 RESPONSE)
Awarded Limited / Sole Source Justification Posted
- Solicitation number
- NIAID-RML-2018841
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93020P00417 Federal contract award
- Awardee
- Bruker Cellular Analysis, Inc.
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Place of performance
- Rockville MD 20852 USA
Notice details come from SAM.gov. Updated .
About this opportunity
This Limited/Sole Source Justification Notice from the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases was for an optofluidic platform from Berkeley Lights to support antibody discovery efforts against COVID-19. Due to the urgent need to identify monoclonal antibodies for treatment and the unique capabilities of Berkeley Lights' Beacon system for high-throughput single-cell screening not available from other sources, a firm-fixed price contract of unknown value was awarded on a sole source basis to Berkeley Lights on March 24, 2020 for a period of performance estimated from March 25 to September 24, 2020 to provide their research-only Beacon platform and allow screening of thousands of cells daily to rapidly identify antibody-secreting cells.
Notice text
This Justification and Approval (J&A) is being posted in compliance with FAR 13.501(a)(iii), within 30 days after placing an order exceeding the simplified acquisition threshold that is supported by an unusual and compelling urgency justification. This order was issued and supported by a Class Justification for Other Than Full and Open Competition (COVID-19 Response) under the authority of 41 U.S.C. 253(c)(1), as set forth in FAR 6.302-2 Unusual and compelling urgency for sole source acquisitions. The J&A and Addendum are provided in the attached package.
Awarded contract 75N93020P00417 to unknown vendor for unknown amount on 2020-03-24.
Files
Similar open opportunities
| Opportunity | Agency | Set-aside | Responses due |
|---|---|---|---|
| 1-Year OEM Service Contract - (2) Revvity Celigo S Imaging Instruments (VRC) | National Institute of Allergy and Infectious Diseases | No set-aside |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity